Nestin-GFP transgenic reporter mouse line

Background
Understanding the intricate processes of neurogenesis and the behavior of neural stem and progenitor cells in both developing and adult nervous systems is crucial, yet it faces considerable obstacles. A primary challenge lies in the difficulty of rapidly identifying, directly visualizing, and efficiently isolating these specific cell populations with high purity. Existing methodologies often lack the precision and scale needed to adequately characterize their differentiation pathways, study their responses to aging, injury, or therapeutic interventions, or to obtain sufficient quantities for detailed molecular analysis, surface marker identification, and transplantation research, thereby impeding comprehensive investigation into their biology and therapeutic applications.
Technology
Researchers at Stony Brook University have developed a transgenic mouse line that expresses green fluorescent protein (GFP) under the control of the nestin gene's regulatory elements. This design specifically marks neural stem and progenitor cells in both embryonic and adult brains, enabling their direct visualization, rapid identification, and high-purity isolation, such as through fluorescent-activated cell sorting. The GFP-positive cells accurately reflect the distribution of nestin-positive cells and neurogenic areas, demonstrating a significantly higher efficiency in generating multipotential neurospheres compared to GFP-negative cells. These GFP-positive cells can be further divided into GFP-bright (GFAP-positive) and GFP-dim (III-tubulin-positive) populations, representing distinct classes of neuronal precursors.
Advantages
- Enhanced visualization of neural stem cells
- Efficient isolation of neural stem cells
- Accurate mapping of neurogenic regions
- Identification of distinct neuronal precursor populations
- In vivo tracking of neurogenesis
- Facilitation of genetic studies
- Improved study of neural stem cell responses
- Potential for transplantation research
Application
- Research Model for Neurogenesis and Neurological Disorders
- Neural Stem Cell Isolation and Analysis
- Drug Discovery and Therapeutic Efficacy Testing
Inventors
Grigori Enikolopov, , Anesthesiology
Licensing Potential
Development partner - Commercial partner - Licensing
Licensing Status
Available
Licensing Contact
Valery Matthys, Licensing Associate, Intellectual Property Partners, valery.matthys@stonybrook.edu,
Stage of Development
Research Data Available
Tech ID
050-9130
